Financials

Income statement, balance sheet and cash flow, built from SEC EDGAR filings.

Braze, Inc.

BRZE · CIK 0001676238

Figures in millions of USD unless the line is a per-share amount or a share count.

Line item Q2 2027 2026-07-31 Q1 2027 2026-04-30 Q4 2026 2026-01-31 Q3 2026 2025-10-31 Q2 2026 2025-07-31 Q1 2026 2025-04-30 Q4 2025 2025-01-31 Q3 2025 2024-10-31
Income Statement
Revenue 227 211 205 191 180 162 160 152
Gross Profit 152 139 134 128 122 111 111 106
Operating Income -18 -28 -28 -38 -39 -40 -22 -33
Pre-Tax Income -16 -24 -25 -34 -35 -35 -16 -27
Net Income -19 -27 -32 -36 -28 -36 -17 -28
EPS (Diluted) -0.17 -0.24 -0.28 -0.33 -0.26 -0.34 -0.16 -0.27
Balance Sheet
Total Assets 1,131 1,091 1,114 1,041 1,023 889 871 842
Total Liabilities 529 508 490 439 423 415 396 384
Shareholders' Equity 600 582 624 602 599 474 475 458
Cash & Equivalents 167 145 124 98 81 231 83 61
Cash Flow
Operating Cash Flow 24 28 19 21 7 24 17 -11
Capital Expenditures -1 0 -5 -2 -3 0 -1 -2
Free Cash Flow 23 28 15 19 4 24 16 -13
Ratios
Gross Margin 66.83% 65.72% 65.48% 67.18% 67.67% 68.62% 69.26% 69.81%
Operating Margin -7.98% -13.04% -13.76% -19.67% -21.52% -24.82% -13.44% -21.42%
Profit Margin -8.30% -12.60% -15.40% -18.86% -15.49% -22.08% -10.72% -18.36%
Free Cash Flow Margin 10.14% 13.28% 7.09% 9.97% 2.41% 14.76% 9.97% -8.77%
Line item Q2 2027 2026-07-31 Q1 2027 2026-04-30 Q4 2026 2026-01-31 Q3 2026 2025-10-31 Q2 2026 2025-07-31 Q1 2026 2025-04-30 Q4 2025 2025-01-31 Q3 2025 2024-10-31
Revenue
Total Revenue 227 211 205 191 180 162 160 152
Cost of Revenue
Cost of Revenue 75 72 71 63 58 51 49 46
Gross Profit
Gross Profit 152 139 134 128 122 111 111 106
Operating Expenses
R&D Expense 45 46 45 44 41 37 34 33
Selling & Marketing 93 89 82 89 83 74 69 75
General & Administrative 32 31 36 33 37 41 30 31
Total Operating Expenses 170 166 163 166 161 151 133 139
Operating Income
Operating Income -18 -28 -28 -38 -39 -40 -22 -33
Non-Operating Items
Other Non-Operating Items 2 3 4 3 4 6 6 5
Pre-Tax Income
Income Before Tax -16 -24 -25 -34 -35 -35 -16 -27
Tax
Income Tax Expense 2 1 7 2 -7 1 1 1
Net Income
Net Income Available to Common -19 -27 -32 -36 -28 -36 -17 -28
EPS
EPS (Basic) -0.17 -0.24 -0.28 -0.33 -0.26 -0.34 -0.16 -0.27
EPS (Diluted) -0.17 -0.24 -0.28 -0.33 -0.26 -0.34 -0.16 -0.27
Shares
Shares Outstanding (Basic) 111 111 113 108 107 105 104 102
Shares Outstanding (Diluted) 111 111 113 108 107 105 104 102
Other Items
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 1 1 0 0 0 0 0 0
Line item Q2 2027 2026-07-31 Q1 2027 2026-04-30 Q4 2026 2026-01-31 Q3 2026 2025-10-31 Q2 2026 2025-07-31 Q1 2026 2025-04-30 Q4 2025 2025-01-31 Q3 2025 2024-10-31
Assets
Total Assets 1,131 1,091 1,114 1,041 1,023 889 871 842
Current Assets 570 547 568 502 485 659 644 613
Current Assets
Cash & Cash Equivalents 167 145 124 98 81 231 83 61
Accounts Receivable, Net 112 118 122 90 88 86 95 90
Prepaid & Other Current Assets 47 40 33 28 31 34 35 30
Non-Current Assets
Property, Plant & Equipment, Net 42 42 44 41 40 39 39 40
Goodwill 262 262 262 267 268 28 28 28
Intangible Assets, Net (excl. Goodwill) 56 58 61 65 68 3 3 3
Other Non-Current Assets 5 4 3 4 4 4 3 4
Operating Lease Right-of-Use Assets 72 71 72 73 73 76 76 80
Liabilities & Equity
Total Liabilities & Equity 1,131 1,091 1,114 1,041 1,023 889 871 842
Liabilities
Total Liabilities 529 508 490 439 423 415 396 384
Current Liabilities
Current Liabilities 450 441 420 369 354 344 324 308
Accounts Payable 2 6 2 4 1 1 2 3
Deferred Revenue, Current 347 343 305 271 262 265 240 224
Operating Lease Liability, Current 19 20 19 20 20 19 18 18
Non-Current Liabilities
Operating Lease Liability, Non-Current 62 62 63 64 64 68 69 74
Other Non-Current Liabilities 5 5 6 6 5 3 2 2
Equity
Total Stockholders' Equity 600 582 624 602 599 474 475 458
Additional Paid-In Capital 1,364 1,326 1,340 1,288 1,249 1,095 1,063 1,027
Retained Earnings (Deficit) -764 -745 -718 -687 -651 -623 -587 -570
Accumulated OCI 0 0 2 0 0 2 -1 0
Other Items
Accounts Receivable, Allowance for Credit Loss, Current 1 2 2 2 2 3 3 3
Restricted Cash, Current 1 1 1 1 1 — 0 0
Common stock, shares authorized — — 2,000 — — — — —
Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current 243 242 288 285 283 308 430 431
Restricted Cash, Noncurrent 3 3 3 3 3 1 1 1
Finance Lease, Right-of-Use Asset, after Accumulated Amortization 15 — 0 — — — — —
Capitalized Contract Cost, Net, Noncurrent 107 104 101 86 82 79 77 72
Accrued expenses and other current liabilities 79 74 95 74 70 58 64 63
Finance Lease, Liability, Current 4 — 0 — — — — —
Finance Lease, Liability, Noncurrent 11 — 0 — — — — —
Redeemable Noncontrolling Interest, Equity, Carrying Amount 2 1 0 0 0 0 0 0
Line item Q2 2027 2026-07-31 Q1 2027 2026-04-30 Q4 2026 2026-01-31 Q3 2026 2025-10-31 Q2 2026 2025-07-31 Q1 2026 2025-04-30 Q4 2025 2025-01-31 Q3 2025 2024-10-31
Operating Activities
Net Income -18 -25 -32 -36 -28 -36 -17 -28
Operating Cash Flow 24 28 19 21 7 24 17 -11
Depreciation & Amortization (CF) — 6 — — — 3 — —
Share-Based Compensation 36 36 38 38 38 31 28 28
Change in Accounts Receivable 6 4 -32 -2 2 9 -5 -21
Change in Accounts Payable -4 4 -2 3 0 -1 -1 -2
Change in Accrued Liabilities 6 -21 20 5 8 -7 2 -1
Change in Deferred Revenue 4 38 33 9 -10 25 16 12
Change in Prepaid & Other Assets -7 -7 -4 3 2 3 -5 1
Provision for Credit Losses 0 0 0 0 0 0 0 2
Other Non-Cash Items — — 0 0 — — 0 0
Investing Activities
Investing Cash Flow -4 43 -7 -6 -161 123 -1 -8
Capital Expenditures -1 0 -5 -2 -3 0 -1 -2
Acquisitions, Net of Cash — — 0 -1 — — 0 0
Maturities of Investments 23 36 38 35 39 63 36 32
Financing Activities
Financing Cash Flow 2 -50 14 1 7 1 6 1
Share Repurchases 0 -50 — — 0 0 — —
Reconciliation
Effect of Exchange Rate Changes 0 0 1 0 0 1 -1 0
Net Change in Cash 21 21 27 16 -146 148 22 -18
Supplemental
Income Taxes Paid 1 2 1 0 1 2 0 1
Other Items
Capitalized Contract Cost, Amortization 13 12 11 10 10 9 9 9
Cost, Depreciation and Amortization — — — 6 — — — 3
Noncash Contribution Expense 1 1 1 1 1 1 1 1
Amortization of Debt Discount (Premium) 0 0 0 0 0 0 0 -1
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax 0 0 — 0 0 0 — 0
Deferred income taxes {1} — 0 — — — 0 — —
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) — — — 0 0 0 — 0
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item — 0 — — — 0 — —
Deferred contract costs -16 -15 -26 -14 -13 -12 -13 -13
ROU assets and liabilities -1 0 0 0 0 0 0 0
Other assets {1} -1 -1 7 0 -8 0 0 -1
Increase (Decrease) in Other Noncurrent Liabilities 1 -3 0 0 0 0 0 0
Payments to Develop Software -1 -1 -1 -1 -1 -1 -1 -1
Payments to Acquire Debt Securities, Available-for-Sale -31 -27 -40 -37 -23 -52 -38 -37
Return of principal on marketable securities 7 35 — 0 7 113 — 0
Payment for Contingent Consideration Liability, Financing Activities — — 0 0 0 0 0 0
Proceeds from Stock Plans 1 0 2 0 3 1 3 0
Stock-based compensation capitalized to internal-use software 1 1 0 1 0 1 0 1
Debt Securities, Available-for-Sale, Unrealized Gain (Loss) -1 -1 0 1 -1 1 0 0
Net change to property and equipment (included in accounts payable/accrued liabilities) 0 0 -1 0 0 1 -1 0
Settlement of Asset Retirement Obligations Through Noncash Payments, Amount 0 0 0 0 0 0 0 0
Excise tax on stock repurchase (included in accrued liabilities) — 0 — — — 0 — —
Goodwill, Measurement Period Adjustment 0 0 — — 0 0 — —
Stock Issued — — 0 1 — — 0 0

Ratios derived from the statements above and the EOD price feed; prices are taken at each period's end date.

Line item Q2 2027 2026-07-31 Q1 2027 2026-04-30 Q4 2026 2026-01-31 Q3 2026 2025-10-31 Q2 2026 2025-07-31 Q1 2026 2025-04-30 Q4 2025 2025-01-31 Q3 2025 2024-10-31
Financial Efficiency
Asset Turnover 0.20 0.19 0.18 0.18 0.18 0.18 0.18 0.18
Current Ratio 1.27 1.24 1.35 1.36 1.37 1.92 1.98 1.99
Debt / EBITDA Ratio — -3.84 — — — -2.32 — —
Debt / Equity Ratio 0.14 0.14 0.13 0.14 0.14 0.18 0.18 0.20
Debt / FCF Ratio 3.52 2.91 5.68 4.41 19.44 3.65 5.47 -6.91
Net Debt / EBITDA Ratio — 3.01 — — — 3.83 — —
Net Debt / Equity Ratio -0.14 -0.11 -0.07 -0.02 0.01 -0.30 0.01 0.07
Net Debt / FCF Ratio -3.72 -2.28 -2.86 -0.73 0.79 -6.03 0.27 -2.31
Quick Ratio 0.62 0.60 0.59 0.51 0.48 0.92 0.55 0.49
Return on Assets (ROA) -1.70% -2.41% -2.93% -3.49% -2.92% -4.07% -2.01% -3.35%
Return on Capital Employed (ROCE) -2.66% -4.24% -4.07% -5.59% -5.79% -7.38% -3.94% -6.10%
Return on Equity (ROE) -3.19% -4.41% -5.16% -6.00% -5.20% -7.54% -3.69% -6.12%
Return on Invested Capital (ROIC) -3.66% -5.13% -5.43% -6.12% -4.63% -10.84% -3.59% -5.71%
Yields
Earnings Yield -0.68% -1.09% -1.35% -1.15% -0.93% -1.09% -0.36% -0.86%
FCF Yield 0.83% 1.15% 0.62% 0.62% 0.15% 0.73% 0.33% -0.41%
Total Valuation
Enterprise Value 2,858 2,505 2,386 3,098 2,973 3,400 4,795 3,183
Last Close Price 24.92 22.03 20.82 28.66 27.87 31.13 45.98 31.46
Market Capitalization 2,772 2,441 2,345 3,085 2,977 3,255 4,799 3,214
EV Ratios
EV/EBIT Ratio -157.70 -91.03 -84.51 -82.53 -76.72 -84.52 -222.40 -97.72
EV/EBITDA Ratio — -117.98 — — — -90.37 — —
EV/FCF Ratio 124.04 89.40 163.96 162.86 684.61 142.08 299.74 -238.71
EV/Sales Ratio 12.58 11.87 11.63 16.24 16.51 20.98 29.89 20.93
Price Ratios
P/FCF Ratio 120.32 87.12 161.09 162.13 685.40 136.05 300.02 -241.02
P/OCF Ratio 114.51 86.78 121.02 147.12 428.18 134.83 280.93 -281.64
P/TBV Ratio 9.81 9.35 7.80 11.40 11.30 7.35 10.83 7.54
PB Ratio 4.62 4.20 3.76 5.12 4.97 6.86 10.11 7.02
PE Ratio -146.59 -91.79 -74.20 -86.85 -107.19 -91.56 -279.17 -116.52
PEG Ratio -5.03 -6.34 -4.96 — -4.56 — -7.16 —
PS Ratio 12.20 11.57 11.43 16.16 16.53 20.09 29.92 21.13